尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Adams Adrian, 董事. Insider active across 5 companies, notably Akebia Therapeutics, Inc.. Aggregated, 14 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €203k. Activity tracked since 2 June 2021. The latest transaction was filed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
ADAMS ADRIAN is Administrateur, Président et Directeur Général. He has 14 filings in total, and across the 14 most recent filings available, the buy amount is EUR 202940, the sell amount is EUR 0, with a date range from 2016-02-09 to 2026-06-24. His listed companies are Akebia Therapeutics, Inc., TALPHERA, INC., Acelrx Pharmaceuticals INC, Impel Neuropharma INC and Aralez Pharmaceuticals Inc.